Dr. Pallavi More-Adate | Nanotechnology | Women Researcher Award
PhD Researcher at School of Health Sciences and Technology,MIT WPU | India
Dr. Pallavi More-Adate is a dedicated researcher and academic specializing in pharmacognosy, nanotechnology, and novel drug delivery systems. She has a strong educational background in pharmaceutical sciences and professional experience in teaching, research, and guiding students in advanced areas of pharmaceutics. Her research primarily focuses on harnessing plant-based bioactive compounds and integrating them into innovative nanocarrier systems for targeted and controlled drug delivery, with a special emphasis on cancer therapeutics and chronic disease management. By bridging traditional medicinal knowledge with modern pharmaceutical approaches, Dr. More-Adate aims to develop sustainable and effective therapeutic solutions.
Professional Profile
Education
Dr. Pallavi More-Adate pursued her academic journey in the pharmaceutical sciences with a strong focus on pharmacognosy and nanomedicine. She earned her Bachelor of Pharmacy, which provided her with a solid foundation in pharmaceutical principles and drug formulation. She went on to complete her Master of Pharmacy in Pharmacognosy, where she deepened her expertise in natural products and their therapeutic applications. Building on this, she obtained her Doctor of Philosophy (Ph.D.) in Pharmacognosy, concentrating her research on nanoformulations of plant extracts for targeted drug delivery, particularly in cancer therapy.
Experience
Dr. Pallavi More-Adate has gained extensive academic and professional experience in the field of pharmaceutical sciences, with a specialization in pharmacognosy and nanomedicine. She has served as an Assistant Professor in the Department of Pharmacognosy, where she has been actively engaged in teaching, mentoring, and guiding undergraduate and postgraduate pharmacy students. Her work includes the development and evaluation of nanoformulations, plant-based drug delivery systems, and natural therapeutic agents, particularly in the area of cancer research. Alongside her academic responsibilities, she has contributed to several research projects, presented at conferences, and published scholarly articles in reputed journals. Her combined expertise in teaching and research reflects her commitment to advancing pharmaceutical education and innovative healthcare solutions.
Research Interests
Dr. Pallavi More-Adate’s research interests lie in the fields of pharmacognosy, nanotechnology, and novel drug delivery systems. She focuses on the development of plant-based bioactive compounds and their application in the formulation of innovative therapeutic agents. Her work emphasizes the use of nanocarriers for targeted and controlled drug delivery, particularly in the treatment of cancer and other chronic diseases. She is also deeply interested in exploring natural products for their pharmacological potential, aiming to bridge traditional medicine with modern pharmaceutical sciences. Her research contributes to advancing sustainable and effective healthcare solutions through innovative drug design and delivery.
Publications
Enhancing Breast Cancer Treatment with Bauhinia variegata capped Copper oxide Nanoparticles: A Sustainable Chemistry Approach
Pharmacoinformatics approach for the screening of Kovidra (Bauhinia variegata) phytoconstituents against tumor suppressor protein in triple negative breast cancer
An in-silico investigation and network pharmacology based approach to explore the anti-breast-cancer potential of Tecteria coadunata (Wall.) C. Chr.
GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro
Conclusion
Dr. Pallavi More-Adate exemplifies the qualities of a dedicated and innovative woman researcher. Her strong foundation in pharmacognosy, phytochemistry, and nanomedicine, combined with her academic leadership and commitment to advancing women in science, make her highly suitable for the Women Researcher Award. With her ongoing contributions and potential for broader international collaborations, she stands as a role model for aspiring women scientists and a valuable contributor to the advancement of pharmaceutical sciences and healthcare innovation.